Scientists track psoriasis drug in nursing Moms' milk
NCT ID NCT06476834
Summary
This study aimed to understand how much of a medication called deucravacitinib, used to treat conditions like psoriasis, passes into breast milk. Researchers measured drug levels in the breast milk and blood of 8 healthy, lactating women after they took a single dose. The goal was to gather safety data to help doctors and nursing mothers make informed decisions about medication use.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Local Institution - 0001
Las Vegas, Nevada, 89113-2246, United States
Conditions
Explore the condition pages connected to this study.